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1. Introduction 
Endogenous carbohydrate binding proteins (lectins) 
have been detected on the cell surface of a variety of 
cell types, including cohesive slime moulds [l-3]. 
Developmental changes in the activities of lectins 
during the differentiation of slime mould cells has led 
to the suggestion that they may mediate the cohesion 
of these cells [4]. In mammalian tissues lectins have 
been detected by their haemagglutination activities 
[5-71; two of which change dramatically during 
embryogenesis [5,8,9]. One lectin activity is P-D- 
galactopyranoside specific and the other is most 
strongly inhibited by certain glycosaminoglycans 
(GAGS) [9-l 11. The biological roles of these lectins 
are not understood, but some authors have suggested 
that during myogenesis they may play a role in myo- 
blast fusion [6,7 ,12 ,131 although this remains contro- 
versial [2,10,14]. We have studied temporal changes 
in lectins prepared from human muscle grown in vitro 
and have detected two lectins which appear to be 
developmentally regulated. We have investigated the 
saccharide specificities of the lectins, extracted from 
human foetal and adult post-mortem skeletal muscle. 
The specificity of human muscle lectins towards P-D- 
galactopyranosides and GAGS is similar to that of lec- 
tins from other species [9-l 11. 
2. Materials and methods 
Phosphate-buffered saline (PBS) was 75 mM NaK 
phosphate, 75 mM NaCl (pH 7.2). Saline was 150 mM 
NaCl. Extraction buffer contained 2 mM EDTA, 4 
mM 2-mercaptoethanol(2ME), 100 mM lactose (BDH, 
Poole) and 100 mM N-acetyl-galactosamine (Sigma, 
London) in PBS. Keratan sulphate, heparan sulphate 
and hyaluronic acid were kindly donated by Professor 
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Matthews (Univ. Chicago). Dermatan sulphate and 
the chondroitin sulphates were purchased from Miles, 
London. 
Soluble lectin extracts were prepared from human 
muscle as follows: l-5 g muscle was homogenized in 
ice-cold extraction buffer (to give 5%, w/v, homog- 
enate) followed by centrifugation at 100 000 X g 
for 1 h at 4°C. The supernatant (containing both lec- 
tins) was centrifuged at 70 000 X g for 18 h and the 
resulting precipitate was resuspended in the original 
volume of PBS (containing 4 mM 2ME and 2 mM 
EDTA). Both the 70 000 X g supernatant (lectin 1) 
and the suspended precipitate (lectin 2) were dialysed 
for 18 h against PBS (containing 4 mM 2ME and 2 
mM EDTA (3 changes, total vol. 10 litres) at 4°C and 
stored at -80°C in aliquots. 
Human muscle was dissociated enzymatically [ 151 
and secondary monolayer cultures were prepared as 
in [ 161. The cells were seeded at a density of 2-3 X 
lO’/lO cm tissue culture plate. Soluble lectin extracts 
were prepared by washing the cells in ice-cold PBS 
and then scraping the cells off the surface of the cul- 
ture dishes into a small volume of ice-cold extraction 
buffer, sonicating on ice and centrifuging at 100 000 X 
g for 1 h at 4°C. The supernatant which contained 
both lectins was dialysed and stored as above. Rabbit 
erythrocytes (type 1 RBC) were collected in Alsever’s 
medium, treated with trypsin and fixed with glutaral- 
dehyde, as in [7]. Type 2 RBC were produced by 
washing type 1 RBC with absolute alcohol [ 171. Haem- 
agglutination tests were performed in Microtiter 
U-shaped wells. The lectin extract (25 fl) was sequen- 
tially diluted 2-fold in each well which contained 25 
1.11 saline. A further 25 ~1 saline (or saccharide in 
saline) was added, followed by 25 ,ul BSA (l%, w/v, 
in saline) and 25 fl RBC (2%, v/v, in PBS). The plates 
were rotated for a few minutes and the titre was read 
after 1 h at room temperature. The titre was defined 
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as the highest dilution of the extract which produced 
agglutination. Lectin activity was expressed as titre-’ 
mg-’ protein present in 25 j_d lectin extract. Protein 
concentrations were determined by the Lowry 
method [ 181 using human serum albumin (Dade) as 
the standard. 
Creatine phosphokinase (EC 2.7.3.2 ,CK) estima- 
tions were carried out on the cell extracts, before 
centrifugation, using a Boehringer UV activated kit 
(no. 124 150) as in [ 191. CK activities are expressed 
as pmol creatine produced . min-’ . mg protein-’ at 
3o”c. 
3. Results 
Two types of soluble lectins have been extracted 
from human muscle. The range of activities in 6 dif- 
ferent extracts was 400-900 titre-’ mg-’ for the first 
type of lectin (lectin I, assayed with RBC I). The 
second type (lectin 2) which agglutinated alcohol- 
washed cells (RBC 2) had a higher activity, ranging 
from 1000-12 000 titre-’ . mg-’ . Prolonged centrifu- 
gation [ 1 l] did not separate these two types of lec- 
tins entirely and both were present in the supernatant 
as well as in the precipitate. The inhibition character- 
istics of the lectins were investigated and the results 
are presented in table 1, as the concentration of 
saccharide or GAG which produced 50% inhibition of 
haemagglutination activity. Type I lectin was specific 
for fl-D-galatopyranoside residues, as described for 
lectins from other mammalian species [lO,l 11. Thio- 
digalactoside (TDG) and lactose were the most potent 
inhibitors (fig.1, table 1). Lectin 2 was strongly inhib- 
ited by heparin and heparan sulphate (fig.:!, table 1). 
Monoclonal antibodies to fibronectin [ 161 did not 
Fig.1. Inhibition of human muscle lectin 1 activity by saccharides. 
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Table 1 
Inhibition of haemagglutination activity of lectin 1 and lectin 2 by various 
saccharides and GAGS 
Saccharide or GAG Concentration (mM) 
inhibiting 50% of 
lectin 1 activity 
Concentration @g/ml) 
inhibiting 50% of 
lectin 2 activity 
TDG 0.04 1 mM 
Lactose 0.20 _ 
Melibiose 6.0 - 
Galactose 10.0 - 
N-Acetylgalactosamine 50.0 5-10 mM 
Xylose, glucose, mannose >lOO.O _ 
Heparin > 100 ug/ml 0.1 
Heparan sulphate _ 25.0 
Dermatan sulphate _ 250.0 
Hyaluronic acid _ 250.0 
Chondroitin 4-sulphate - 1000.0 
Chondroitin 6-sulphate - 2000 .o 
Keratan sulphate _ > 1000.0 
Lectin 1 was tested with RBCl and lectin 2 with RBC 2 as in section 2. With fresh 
extracts, wells containing high concentrations of lectin 2 showed no agglutination. 
This high concentration inhibition has been described in [ 1 I ] 
Table 2 
Lectin and CK activities in secondary human muscle cultures (prepared from 
20 week foetus) 
No. of days Lectin 1 Lectin 2 CK at 30°C 
in culture (titre-r .mg-r) (titre-’ . mg-‘) (urn01 mm-’ mg-‘) 
1 226 2606 0.30 
3 528 8476 0.71 
4 500 8000 0.95 
Fusion was observed to commence on day 2: lectin 1, activity was inhibited by 
1 mM TDG; lectin 2, activity was inhibited by 0.1 mg/ml heparin 
inhibit haemagghttination. Temporal changes in lectin 
activities were followed in extracts of replicate sec- 
ondary foetal muscle cultures and the results of one 
experiment are shown in table 1. The levels of lectins 
increased at least 2-fold during the fusion of myoblasts 
to myotubes. There was a concomitant increase in 
the activity of CK, an enzyme marker of muscle cell 
differentiation [20]. 
The final degree of differentiation of this culture 
was relatively high, with a high CK value (1.24 
pm01 . min-r . ml-‘) and a large proportion of broad, 
branched myotubes containing numerous nuclei. 
The levels of lectin 1 and 2 in the dialysed growth 
medium (60 titre-’ . mg -’ for both lectins) did not 
change during the growth and differentiation of this 
culture [ 171. 
Muscle cultures prepared from an 8 week foetus 
differentiated poorly, exhibiting a constant low CK 
level during the growth period (table 3). Only a few 
thin myotubes containing few nuclei were seen. No 
changes in either lectin activity were detected during 
the development of these cultures (table 3). 
In all cultures prepared from 6 different muscle 
specimens, the activities of lectin 2 (2600-17 500 
titre-’ . mg-‘) were higher than lectin 1 (200-800 
titre-1 . mg-‘). 
4. Discussion 
The present study indicates that human skeletal 
muscle contains two soluble lectins which can be 
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Fig.2. Inhibition of human muscle lectin 2 activity by glycosaminoglycans. 
Table 3 
Lectin and CK activities in human muscle cultures prepared from 28 week foetus 
No. of days Lectin 1 Lectin 2 CK at 3O’C 
in culture titre-’ . mg-r) titre-r . mg-r) (gmol . mm-‘. mg-‘) 
3 800 6400 0.28 
4 760 6094 0.25 
5 888 6110 0.27 
6 850 6808 0.14 
The first myotubes were observed on day 4 
detected by their haemagglutination activities. The lectin 2; heparin being 20-fold more potent as an 
haemagglutination activities of human muscle lectin I inhibitor of human muscle lectin compared to chick 
is inhibited by galactosecontaining saccharides and is muscle lectin [7]. However, dermatan sulphate is only 
more sensitive to TDG, lactose, melibiose, galactose a weak inhibitor of the human muscle lectin. Heparin 
and N-acetyl-galactosamine than the crude chick and heparan sulphate contain galactose, as well as 
embryo muscle lectin [7]. The GAGS, heparin and xylose and the saccharide repeating units consist of 
heparan sulphate are the most potent inhibitors of glucuronic and iduronic acids and glucosamine [21]. 
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Lectin 2 doesnot appear to be identical to fibronectin, 
an extracellular protein with haemagglutination activ- 
ity and the capacity to interact with heparin, as anti- 
bodies to fibronectin do not inhibit agglutination 
[ 171. Increases in both lectin 1 and lectin 2 were 
found during the fusion of human myoblasts, resem- 
bling the changes in lectin 1 activity reported in 
extracts of cultures of the L6 muscle cell line [ 1,6,7 
121. In contrast, there were no changes in lectin 1 and 
2 in primary chick embryo muscle cultures, although 
lectin 2 activity was detected in the growth medium 
after fusion [ 171. We have found no evidence for 
increases in either lectin activity in dialysed growth 
medium from human muscle cultures even after 
extensive myoblast fusion and myotube differentia- 
tion was observed, in contrast to the reports of others 
[ 171. The involvement of a galactosyl-specific lectin 
in myoblast fusion has been investigated by the inclu- 
sion of TDG in the cell growth medium, This pro- 
duced inhibition of fusion in the L6 muscle line [6] 
but not in primary cultures of chick embryonic muscle 
[ 141, rat muscle [2 ] or human skeletal muscle (Dr 
Rose Yasin, personal communication). Therefore the 
role of endogenous lectins in muscle remains unclear. 
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